in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Codexis, Purolite collaborate to develop immobilized enzymes for pharmaceutical market
July 17, 2013 | Deepti Ramesh
Codexis (Redwood City, CA), a company that engineers enzymes for pharmaceutical, biofuel, and chemical productions, says it has entered into a collaboration with Purolite (Bala Cynwyd, PA), to develop and market immobilized enzymes for the pharmaceutical industry. Purolite is a leading manufacturer of ion exchange, catalyst, adsorbent, and specialty resins, Codexis says. Enzymes are immobilized by binding to inert resins, allowing for the easier separation from a reaction mixture; and immobilization often allows for the use of these enzymes under different...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee